Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial
PGT121（一种广谱中和HIV-1单克隆抗体）的安全性、药代动力学和抗病毒活性：一项随机、安慰剂对照的I期临床试验
期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-021-01509-0
Stephenson, Kathryn E; Julg, Boris; Tan, C Sabrina; Zash, Rebecca; Walsh, Stephen R; Rolle, Charlotte-Paige; Monczor, Ana N; Lupo, Sofia; Gelderblom, Huub C; Ansel, Jessica L; Kanjilal, Diane G; Maxfield, Lori F; Nkolola, Joseph; Borducchi, Erica N; Abbink, Peter; Liu, Jinyan; Peter, Lauren; Chandrashekar, Abishek; Nityanandam, Ramya; Lin, Zijin; Setaro, Alessandra; Sapiente, Joseph; Chen, Zhilin; Sunner, Lisa; Cassidy, Tyler; Bennett, Chelsey; Sato, Alicia; Mayer, Bryan; Perelson, Alan S; deCamp, Allan; Priddy, Frances H; Wagh, Kshitij; Giorgi, Elena E; Yates, Nicole L; Arduino, Roberto C; DeJesus, Edwin; Tomaras, Georgia D; Seaman, Michael S; Korber, Bette; Barouch, Dan H
